Other languages ExpreS2ion Biotech Holding AB

Equities

EXPRS2

SE0008348262

Delayed Nasdaq Stockholm Other stock markets 08:59:58 2024-05-17 EDT			5-day change	1st Jan Change
1.402 ^SEK	-1.41%		-4.63%	-33.55%

05-16	ExpreS2ion Biotech Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-16	ExpreS2ion Announces Completion of GLP Safety Study for ES2B-C001 (HER2-VLP) Breast Cancer Vaccine Candidate	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ExpreS2ion Biotech Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	05-16
ExpreS2ion Announces Completion of GLP Safety Study for ES2B-C001 (HER2-VLP) Breast Cancer Vaccine Candidate	04-16
ExpreS2ion Biotech JV Secures EUR10 Million Following Bavarian Nordic's Completion of COVID-19 Vaccine Trial	02-21
ExpreS2ion Biotech Unit Secures EUR8 Million Grant for Virus Vaccine Project; Shares Soar	12-01
ExpreS2ion Biotech Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-16
ExpreS2ion Biotech Holding AB Announces Changes to Leadership Team	23-09-27
Expres2ion Biotech Affiliate to Assess Strategic Options for Breast Cancer Project	23-08-17
ExpreS2ion Biotech Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-17
ExpreS2ion Biotech Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-16
ExpreS2ion Biotech Holding AB Auditor Raises 'Going Concern' Doubt	23-05-01
ExpreS2ion Biotech to Issue New Units to Guarantors Under Rights Issue	23-04-21
ExpreS2ion Biotech Holding AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-09
ExpreS2ion Biotech Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-09
ExpreS2ion Biotech Holding AB Appoints Dr. Farshad Guirakhoo as Chief Scientific Officer, Effective January 16, 2023	23-01-03
ExpreS2ion and Evaxion Biotech A/S Initiates Research Collaboration on a Novel Cytomegalovirus Vaccine Candidate	22-12-06
ExpreS2ion Biotech Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-17
Expres2ion Biotech Holding AB Announces Durable Antibody Response Reported for the Abncov2 Covid-19 Vaccine Six Months After Vaccination in the Phase Ii Clinical Trial	22-10-17
ExpreS2ion Biotech Holding AB Announces Resignation of Allan Rosetzsky from the Board of Directors	22-10-06
ExpreS2ion Biotech Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-18
ExpreS2ion Biotech Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages ExpreS2ion Biotech Holding AB

Equities

EXPRS2

SE0008348262

Other languages

Filters